Research Article
Formation of Polyploid Giant Cancer Cells Involves in the Prognostic Value of Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer
Table 3
Clinicopathological characteristics in 304 cases of locally advanced rectal cancer patients treated with neoadjuvant chemoradiation therapy (nCRT).
| | AJCC and CAP regression score | Chi-square | value | Total | CR | PR | SD | PD |
| Number of patients | 304 | 29 (9.54%) | 125 (41.12%) | 138 (45.39%) | 12 (3.95%) | | | Age (years), mean | 60.02 | 61.09 | 59.40 | 59.61 | 66.58 | 4.830 | 0.185 | Sex | | | | | | | | Male | 206 (67.76%) | 20 (9.71%) | 85 (41.26%) | 92 (44.66%) | 9 (4.37%) | | | Female | 98 (32.24%) | 9 (9.18%) | 40 (40.82%) | 46 (46.94%) | 3 (3.06%) | 0.3355 | 0.953 | Rest interval (d), mean | 68.46 | 69.10 | 55.29 | 72.97 | 152.17 | 6.733 | 0.081 | Pathology N stage◆ | | | | | | 440.120 | 0.001 | Complete response | 27 (8.91%) | 25 (92.59%) | 2 (7.41%) | 0 | 0 | | | T1 | 9 (2.97%) | 0 | 8 (88.89%) | 1 (11.11%) | 0 | | | T2 | 43 (14.19%) | 1 (2.33%) | 25 (58.14%) | 17 (39.53%) | 0 | | | T3 | 197 (65.02%) | 3 (1.52%) | 83 (42.13%) | 111 (56.35%) | 0 | | | T4 | 27 (8.91%) | 0 | 6 (22.22%) | 9 (33.33%) | 12 (44.44%) | | | Pathology N stage | | | | | | 18.007 | 0.001 | N0 | 184 (65.02%) | 27 (14.67%) | 80 (43.48%) | 77 (41.85%) | 0 | | | N1 | 72 (25.44%) | 0 | 25 (34.72%) | 47 (65.28%) | 0 | | | N2 | 27 (9.54%) | 2 (7.41%) | 12 (44.44%) | 13 (48.15%) | 0 | | | Histological type▼ | | | | | | 24.617 | 0.001 | Mucinous carcinoma | 59 (21.22%) | 11 (18.64%) | 27 (45.76%) | 21 (35.59%) | 0 | | | Nonmucinous carcinoma | 219 (78.78%) | 5 (2.28%) | 97 (44.29%) | 117 (53.42%) | 0 | | | Histological differentiation△ | | | | | | 1.781 | 0.411 | Well + moderately | 190 (88.79%) | 3 (1.58%) | 86 (45.26%) | 101 (53.16%) | 0 | | | Poor | 24 (11.21%) | 0 | 8 (33.33%) | 16 (66.67%) | 0 | | |
|
|
◆1 missing value; 21 missing values; ▼26 missing values; △90 missing values. CR, complete remission; PR, partial remission; PD, progressive disease; SD, stable disease; AJCC, American Joint Committee on Cancer; CAP, College of American Pathologists; nCRT, neoadjuvant chemoradiation therapy. |